TREACE MEDICAL CONCEPTS, INC.
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
TMCI$4.03-3.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations and Comprehensive Loss
(in thousands, except share and per share amounts)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Revenue | $212,690 | $209,357 | $187,118 |
| Cost of goods sold | 42,938 | 41,093 | 35,181 |
| Gross profit | 169,752 | 168,264 | 151,937 |
| Operating expenses | |||
| Sales and marketing | 140,880 | 147,643 | 140,894 |
| Research and development | 20,282 | 20,589 | 15,440 |
| General and administrative | 62,744 | 55,720 | 47,031 |
| Total operating expenses | 223,906 | 223,952 | 203,365 |
| Loss from operations | (54,154) | (55,688) | (51,428) |
| Interest income | 2,777 | 4,877 | 6,726 |
| Interest expense | (5,320) | (5,256) | (5,167) |
| Debt extinguishment loss | (2,737) | — | — |
| Other income, net | 432 | 324 | 342 |
| Other non-operating income (expense), net | (4,848) | (55) | 1,901 |
| Net loss | (59,002) | (55,743) | (49,527) |
| Other comprehensive income (loss) | |||
| Unrealized gain (loss) on marketable securities | (25) | (66) | 190 |
| Comprehensive loss | $(59,027) | $(55,809) | $(49,337) |
| Net loss per share, basic and diluted | $(0.93) | $(0.90) | $(0.81) |
| Weighted-average shares used in computing net loss per share, basic and diluted | 63,269,003 | 62,112,037 | 60,852,153 |
Treace Medical Concepts Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.